Role of inflammasome in severe, steroid-resistant asthma

[1]  S. Weinberg,et al.  IL-17A Mediates Pyroptosis via ERK Pathway and Contributes to Steroid Resistance in CRSwNP. , 2022, The Journal of allergy and clinical immunology.

[2]  I. Adcock,et al.  Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma. , 2021, The Journal of allergy and clinical immunology.

[3]  Dong-Wook Kwak,et al.  Leukotriene B4 Receptors Are Necessary for the Stimulation of NLRP3 Inflammasome and IL-1β Synthesis in Neutrophil-Dominant Asthmatic Airway Inflammation , 2021, Biomedicines.

[4]  G. Koppelman,et al.  The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention. , 2021, Pharmacology & therapeutics.

[5]  E. Latz,et al.  Necroptosis, pyroptosis and apoptosis: an intricate game of cell death , 2021, Cellular & Molecular Immunology.

[6]  Dong-Wook Kwak,et al.  Leukotriene B4 receptors contribute to house dust mite-induced eosinophilic airway inflammation via TH2 cytokine production , 2021, BMB reports.

[7]  Yaxue Zhao,et al.  Lycorine ameliorates bleomycin-induced pulmonary fibrosis via inhibiting NLRP3 inflammasome activation and pyroptosis. , 2020, Pharmacological research.

[8]  X. Xia,et al.  Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases , 2020, Journal of cellular physiology.

[9]  Xizhe Li,et al.  The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases. , 2020, Journal of dermatological science.

[10]  T. Greulich,et al.  Caspase-11 promotes allergic airway inflammation , 2020, Nature Communications.

[11]  Xiaoxia Li,et al.  Targeting IL-17A/glucocorticoid synergy to CSF3 expression in neutrophilic airway diseases. , 2020, JCI insight.

[12]  Wei Wei,et al.  The advances in pyroptosis initiated by inflammasome in inflammatory and immune diseases , 2020, Inflammation Research.

[13]  So Ri Kim,et al.  Epithelial PI3K-δ Promotes House Dust Mite-Induced Allergic Asthma in NLRP3 Inflammasome-Dependent and -Independent Manners , 2020, Allergy, asthma & immunology research.

[14]  D. Price,et al.  Characterization of severe asthma worldwide: data from the International Severe Asthma Registry (ISAR). , 2019, Chest.

[15]  E. Lien,et al.  Gasdermins and their role in immunity and inflammation , 2019, The Journal of experimental medicine.

[16]  J. Lieberman,et al.  Gasdermin D activity in inflammation and host defense , 2019, Science Immunology.

[17]  L. Lei,et al.  The role of pyroptosis in cancer: pro-cancer or pro-“host”? , 2019, Cell Death & Disease.

[18]  Kenneth R. Jeffries,et al.  Apolipoprotein E is a concentration-dependent pulmonary danger signal that activates the NLRP3 inflammasome and IL-1β secretion by bronchoalveolar fluid macrophages from asthmatic subjects. , 2019, The Journal of allergy and clinical immunology.

[19]  W. Tan,et al.  Pharmacological strategies to regain steroid sensitivity in severe asthma and COPD. , 2019, Current opinion in pharmacology.

[20]  Hongmei Tan,et al.  Role of Pyroptosis in Cardiovascular Diseases and its Therapeutic Implications , 2019, International journal of biological sciences.

[21]  E. Bleecker,et al.  Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma , 2019, American journal of respiratory and critical care medicine.

[22]  Jae-Hong Kim,et al.  Leukotriene B4 receptors mediate the production of IL‐17, thus contributing to neutrophil‐dominant asthmatic airway inflammation , 2019, Allergy.

[23]  Huanwen Chen,et al.  Role of pyroptosis in cardiovascular diseases. , 2019, International immunopharmacology.

[24]  E. Latz,et al.  Charcot–Leyden Crystals Activate the NLRP3 Inflammasome and Cause IL-1β Inflammation in Human Macrophages , 2018, The Journal of Immunology.

[25]  M. Frédérich,et al.  An ethnobotanical survey and inhibitory effects on NLRP3 inflammasomes/Caspase-1 of herbal recipes' extracts traditionally used in Rwanda for asthma treatment. , 2018, Journal of ethnopharmacology.

[26]  C. Akdis,et al.  Tight junction, mucin, and inflammasome‐related molecules are differentially expressed in eosinophilic, mixed, and neutrophilic experimental asthma in mice , 2018, Allergy.

[27]  Huimei Wu,et al.  Estrogen ameliorates allergic airway inflammation by regulating activation of NLRP3 in mice , 2018, Bioscience reports.

[28]  F. E. Lee,et al.  Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease , 2018, Clinical Reviews in Allergy & Immunology.

[29]  I. Chung,et al.  Inflammatory mediators ATP and S100A12 activate the NLRP3 inflammasome to induce MUC5AC production in airway epithelial cells. , 2018, Biochemical and biophysical research communications.

[30]  E. Bleecker,et al.  Refractory airway type 2 inflammation in a large subgroup of asthmatic patients treated with inhaled corticosteroids , 2018, The Journal of allergy and clinical immunology.

[31]  S. Kabra,et al.  Advances in Asthma , 2018, The Indian Journal of Pediatrics.

[32]  I. Mahmutovic Persson,et al.  IL-1β mediates lung neutrophilia and IL-33 expression in a mouse model of viral-induced asthma exacerbation , 2018, Respiratory Research.

[33]  E. Israel,et al.  A functional splice variant associated with decreased asthma risk abolishes the ability of gasdermin B to induce epithelial cell pyroptosis , 2018, The Journal of allergy and clinical immunology.

[34]  N. Jarjour,et al.  Sputum cell IL‐1 receptor expression level is a marker of airway neutrophilia and airflow obstruction in asthmatic patients , 2017, The Journal of allergy and clinical immunology.

[35]  N. Koulouris,et al.  Clinical, functional and inflammatory characteristics in patients with paucigranulocytic stable asthma: Comparison with different sputum phenotypes , 2017, Allergy.

[36]  E. Israel,et al.  Severe and Difficult‐to‐Treat Asthma in Adults , 2017, The New England journal of medicine.

[37]  Ryan D. Huff,et al.  Regulation of xanthine dehydrogensase gene expression and uric acid production in human airway epithelial cells , 2017, PloS one.

[38]  Daniel C. Lazar,et al.  A bioluminescent caspase-1 activity assay rapidly monitors inflammasome activation in cells. , 2017, Journal of immunological methods.

[39]  L. Wood,et al.  Role for NLRP3 Inflammasome‐mediated, IL‐1&bgr;‐Dependent Responses in Severe, Steroid‐Resistant Asthma , 2017, American journal of respiratory and critical care medicine.

[40]  L. Wood,et al.  Mechanisms and treatments for severe, steroid‐resistant allergic airway disease and asthma , 2017, Immunological reviews.

[41]  C. Auffray,et al.  Sputum transcriptomics reveal upregulation of IL‐1 receptor family members in patients with severe asthma , 2017, The Journal of allergy and clinical immunology.

[42]  Wenqing Gao,et al.  Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death. , 2017, Trends in biochemical sciences.

[43]  I. Adcock,et al.  MicroRNA‐21 drives severe, steroid‐insensitive experimental asthma by amplifying phosphoinositide 3‐kinase–mediated suppression of histone deacetylase 2 , 2017, The Journal of allergy and clinical immunology.

[44]  O. Herzberg,et al.  Gene polymorphism linked to increased asthma and IBD risk alters gasdermin-B structure, a sulfatide and phosphoinositide binding protein , 2017, Proceedings of the National Academy of Sciences.

[45]  N. Câmara,et al.  Soluble Uric Acid Activates the NLRP3 Inflammasome , 2017, Scientific Reports.

[46]  R. Troncoso,et al.  Glucocorticoid resistance in chronic diseases , 2016, Steroids.

[47]  Q. Hamid,et al.  GSDMB induces an asthma phenotype characterized by increased airway responsiveness and remodeling without lung inflammation , 2016, Proceedings of the National Academy of Sciences.

[48]  Junjie Zhu,et al.  Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS , 2016, Cell Death and Disease.

[49]  V. Dixit,et al.  Inflammasomes: mechanism of assembly, regulation and signalling , 2016, Nature Reviews Immunology.

[50]  Jonathan L. Schmid-Burgk,et al.  Human Monocytes Engage an Alternative Inflammasome Pathway. , 2016, Immunity.

[51]  P. Gibson,et al.  Neutrophil extracellular traps are associated with inflammation in chronic airway disease , 2016, Respirology.

[52]  L. Borthwick.  The IL-1 cytokine family and its role in inflammation and fibrosis in the lung , 2016, Seminars in Immunopathology.

[53]  D. Green,et al.  Critical role of caspase-8–mediated IL-1 signaling in promoting Th2 responses during asthma pathogenesis , 2016, Mucosal Immunology.

[54]  G. Dubyak,et al.  Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP , 2016, Nature Communications.

[55]  D. Lang.  Severe asthma: epidemiology, burden of illness, and heterogeneity. , 2015, Allergy and asthma proceedings.

[56]  K. Schroder,et al.  NLRP3 inflammasome activation downstream of cytoplasmic LPS recognition by both caspase‐4 and caspase‐5 , 2015, European journal of immunology.

[57]  S. Kummerfeld,et al.  Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling , 2015, Nature.

[58]  S. Zheng,et al.  Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation. , 2015, Journal of molecular cell biology.

[59]  P. Foster,et al.  MicroRNA-9 regulates steroid-resistant airway hyperresponsiveness by reducing protein phosphatase 2A activity. , 2015, The Journal of allergy and clinical immunology.

[60]  G. Dubyak,et al.  Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling* , 2015, The Journal of Biological Chemistry.

[61]  Seamus J. Martin,et al.  Proteolytic Processing of Interleukin-1 Family Cytokines: Variations on a Common Theme. , 2015, Immunity.

[62]  E. Miao,et al.  Pyroptotic cell death defends against intracellular pathogens , 2015, Immunological reviews.

[63]  K. Schroder,et al.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.

[64]  G. Dubyak,et al.  Neutrophil IL-1β Processing Induced by Pneumolysin Is Mediated by the NLRP3/ASC Inflammasome and Caspase-1 Activation and Is Dependent on K+ Efflux , 2015, The Journal of Immunology.

[65]  J. Fahy.  Type 2 inflammation in asthma — present in most, absent in many , 2014, Nature Reviews Immunology.

[66]  K. Lee,et al.  NLRP3 inflammasome activation by mitochondrial ROS in bronchial epithelial cells is required for allergic inflammation , 2014, Cell Death and Disease.

[67]  O. Ohara,et al.  Single-cell imaging of caspase-1 dynamics reveals an all-or-none inflammasome signaling response. , 2014, Cell reports.

[68]  V. Natarajan,et al.  Reactive oxygen species at the crossroads of inflammasome and inflammation , 2014, Front. Physiol..

[69]  J. Tschopp,et al.  The neutrophil NLRC4 inflammasome selectively promotes IL-1β maturation without pyroptosis during acute Salmonella challenge. , 2014, Cell reports.

[70]  E. Bleecker,et al.  International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma , 2013, European Respiratory Journal.

[71]  S. Phipps,et al.  Elevated expression of the NLRP3 inflammasome in neutrophilic asthma , 2013, European Respiratory Journal.

[72]  S. Johnston,et al.  The emerging role of microRNAs in regulating immune and inflammatory responses in the lung , 2013, Immunological reviews.

[73]  John Calvin Reed,et al.  The CARD plays a critical role in ASC foci formation and inflammasome signalling. , 2013, The Biochemical journal.

[74]  P. Foster,et al.  Th2 cytokine antagonists: potential treatments for severe asthma , 2013, Expert opinion on investigational drugs.

[75]  A. Baccarelli,et al.  Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[76]  Anna K Rieger,et al.  NLRP3 Inflammasome Activity Is Negatively Controlled by miR-223 , 2012, The Journal of Immunology.

[77]  B. Koller,et al.  NLRP1-Dependent Pyroptosis Leads to Acute Lung Injury and Morbidity in Mice , 2012, The Journal of Immunology.

[78]  R. Bucala.  Approaching the immunophysiology of steroid resistance , 2012, Arthritis Research & Therapy.

[79]  X. Hua,et al.  Analysis of NLRP3 in the Development of Allergic Airway Disease in Mice , 2012, The Journal of Immunology.

[80]  B. Monsarrat,et al.  IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G , 2012, Proceedings of the National Academy of Sciences.

[81]  Jinfeng Liu,et al.  Non-canonical inflammasome activation targets caspase-11 , 2011, Nature.

[82]  J. Cidlowski,et al.  Glucocorticoids Sensitize the Innate Immune System through Regulation of the NLRP3 Inflammasome* , 2011, The Journal of Biological Chemistry.

[83]  A. Aderem,et al.  Caspase‐1‐induced pyroptotic cell death , 2011, Immunological reviews.

[84]  R. Hoffmann,et al.  Interleukin-17A induces glucocorticoid insensitivity in human bronchial epithelial cells , 2011, European Respiratory Journal.

[85]  P. Barnes.  Biochemical Basis of Asthma Therapy* , 2011, The Journal of Biological Chemistry.

[86]  M. Birrell,et al.  The role of the NLRP3 inflammasome in the pathogenesis of airway disease. , 2011, Pharmacology & therapeutics.

[87]  P. Foster,et al.  Interleukin-13 Promotes Susceptibility to Chlamydial Infection of the Respiratory and Genital Tracts , 2011, PLoS pathogens.

[88]  H. Hammad,et al.  An unexpected role for uric acid as an inducer of T helper 2 cell immunity to inhaled antigens and inflammatory mediator of allergic asthma. , 2011, Immunity.

[89]  A. Aderem,et al.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria , 2010, Nature Immunology.

[90]  Rakesh K. Kumar,et al.  IL-27/IFN-γ Induce MyD88-Dependent Steroid-Resistant Airway Hyperresponsiveness by Inhibiting Glucocorticoid Signaling in Macrophages , 2010, The Journal of Immunology.

[91]  Florence Demenais,et al.  A large-scale, consortium-based genomewide association study of asthma. , 2010, The New England journal of medicine.

[92]  J. Martin,et al.  Induction of glucocorticoid receptor‐β expression in epithelial cells of asthmatic airways by T‐helper type 17 cytokines , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[93]  P. Foster,et al.  Potential therapeutic targets for steroid-resistant asthma. , 2010, Current Drug Targets.

[94]  D. Umetsu,et al.  The many paths to asthma: phenotype shaped by innate and adaptive immunity , 2010, Nature Immunology.

[95]  V. Hornung,et al.  Critical functions of priming and lysosomal damage for NLRP3 activation , 2010, European journal of immunology.

[96]  J. Alcorn,et al.  TH17 cells in asthma and COPD. , 2010, Annual review of physiology.

[97]  P. Hansbro,et al.  Harnessing regulatory T cells to suppress asthma: from potential to therapy. , 2010, American journal of respiratory cell and molecular biology.

[98]  Yusuke Nakamura,et al.  A functional polymorphism in IL-18 is associated with severity of bronchial asthma. , 2009, American journal of respiratory and critical care medicine.

[99]  D. Golenbock,et al.  Inflammasomes: too big to miss. , 2009, The Journal of clinical investigation.

[100]  S. Cullen,et al.  Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. , 2009, Immunity.

[101]  E. Alnemri,et al.  Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression1 , 2009, The Journal of Immunology.

[102]  J. Girard,et al.  The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1 , 2009, Proceedings of the National Academy of Sciences.

[103]  I. Adcock,et al.  Glucocorticoid resistance in inflammatory diseases , 2009, The Lancet.

[104]  C. Gabay,et al.  Interleukin-33 Is Biologically Active Independently of Caspase-1 Cleavage* , 2009, The Journal of Biological Chemistry.

[105]  Richard A Flavell,et al.  Innate instruction of adaptive immunity revisited: the inflammasome , 2009, EMBO molecular medicine.

[106]  R. Nurieva,et al.  Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. , 2009, Immunity.

[107]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[108]  B. Cookson,et al.  Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.

[109]  J. Alcorn,et al.  TH17 Cells Mediate Steroid-Resistant Airway Inflammation and Airway Hyperresponsiveness in Mice1 , 2008, The Journal of Immunology.

[110]  I. Adcock,et al.  Steroid resistance in asthma: Mechanisms and treatment options , 2008, Current allergy and asthma reports.

[111]  Henk C. Hoogsteden,et al.  Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells , 2008, The Journal of experimental medicine.

[112]  B. Cookson,et al.  Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.

[113]  J. Douwes,et al.  Innate immune activation in neutrophilic asthma and bronchiectasis , 2007, Thorax.

[114]  H. Forman,et al.  ATP Activates a Reactive Oxygen Species-dependent Oxidative Stress Response and Secretion of Proinflammatory Cytokines in Macrophages* , 2007, Journal of Biological Chemistry.

[115]  C. Charron,et al.  Mode of Glucocorticoid Actions in Airway Disease , 2006, TheScientificWorldJournal.

[116]  M. Ege,et al.  The asthma epidemic. , 2006, The New England journal of medicine.

[117]  G. Lukács,et al.  Importin 13 regulates nuclear import of the glucocorticoid receptor in airway epithelial cells. , 2006, American journal of respiratory cell and molecular biology.

[118]  I. Adcock,et al.  Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression , 2006, The Journal of experimental medicine.

[119]  J. Cidlowski,et al.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs. , 2005, The New England journal of medicine.

[120]  P. Chanez.  Severe asthma is an epithelial disease , 2005, European Respiratory Journal.

[121]  I. Adcock,et al.  Histone Deacetylation: An Important Mechanism in Inflammatory Lung Diseases , 2005, COPD.

[122]  Alejandra Bruna,et al.  Glucocorticoid receptor–JNK interaction mediates inhibition of the JNK pathway by glucocorticoids , 2003, The EMBO journal.

[123]  Lung-Chi Chen,et al.  Airway epithelial cells release MIP-3alpha/CCL20 in response to cytokines and ambient particulate matter. , 2003, American journal of respiratory cell and molecular biology.

[124]  A. V. van Kuilenburg,et al.  Histone deacetylases (HDACs): characterization of the classical HDAC family. , 2003, The Biochemical journal.

[125]  Lung-Chi Chen,et al.  Size fractions of ambient particulate matter induce granulocyte macrophage colony-stimulating factor in human bronchial epithelial cells by mitogen-activated protein kinase pathways. , 2002, American journal of respiratory cell and molecular biology.

[126]  F. Martinon,et al.  The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.

[127]  J. Fahy,et al.  Remodeling of the airway epithelium in asthma. , 2001, American journal of respiratory and critical care medicine.

[128]  J. Hogg,et al.  Particulate matter induces cytokine expression in human bronchial epithelial cells. , 2001, American journal of respiratory cell and molecular biology.

[129]  J. Cidlowski,et al.  The dominant negative activity of the human glucocorticoid receptor beta isoform. Specificity and mechanisms of action. , 1999, The Journal of biological chemistry.

[130]  S. Wenzel,et al.  Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. , 1999, American journal of respiratory and critical care medicine.

[131]  R. Kamen,et al.  Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN- γ production , 1997, Nature.

[132]  K. Horwitz,et al.  Nuclear receptor coactivators and corepressors. , 1996, Molecular endocrinology.

[133]  P. Barnes,et al.  Inhaled glucocorticoids for asthma. , 1995, The New England journal of medicine.

[134]  R. Kimberly.  Glucocorticoids , 2020, Reactions Weekly.

[135]  K. O. Elliston,et al.  A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.

[136]  Dirk E. Smith,et al.  The nucleotide-binding domain, leucine-rich repeat protein 3 inflammasome/IL-1 receptor I axis mediates innate, but not adaptive, immune responses after exposure to particulate matter under 10 μm. , 2015, American journal of respiratory cell and molecular biology.

[137]  J. Tschopp,et al.  The Inflammasomes , 2010, Cell.

[138]  P. Hart,et al.  S100A12 provokes mast cell activation: a potential amplification pathway in asthma and innate immunity. , 2007, The Journal of allergy and clinical immunology.